Electro-Polished Pharmaceutical Reactors for Vaccine Development
Roben Mfg, Inc. fabricates electro-polished pharmaceutical reactors for vaccine development applications. Our sterile vessels support vaccine research and clinical manufacturing with the surface quality, contamination control, and documentation these critical healthcare products require.
Electro-Polished Reactors for Vaccine Development
Vaccine development requires vessels that maintain absolute sterility while providing the flexibility for process development and optimization. Our electro-polished pharmaceutical reactors support antigen production, formulation development, and clinical manufacturing with consistent quality from research through commercial-scale validation.
Why Choose Electro-Polished Pharmaceutical Reactors for Vaccine Development from Roben Mfg?
- Sterile processing capability
- Development flexibility
- Scale-up pathway
- Contamination control
- Regulatory documentation
- Clinical manufacturing ready
- Process optimization support
Key Features
- Ultra-clean electro-polished surfaces
- Validated SIP capability
- Sterile connections
- Comprehensive instrumentation
- Flexible configuration
- Complete documentation
- Scale-down capability
Applications
- Antigen production development
- Formulation optimization
- Adjuvant studies
- Stability testing support
- Clinical batch production
- Process characterization
- Scale-up validation
- Technology transfer
Compliance and Certifications
Roben Mfg maintains comprehensive certifications ensuring our electro-polished pharmaceutical reactors meet the highest industry standards:
- ASME Section VIII Division 1 and Division 2 — “U” and “U2” Stamps
- ASME BPE (Bioprocessing Equipment) compliance
- National Board “R” Stamp for repairs and alterations
- ISO 9001:2015 Quality Management System
- PED (Pressure Equipment Directive) for European market
- FDA 21 CFR Part 11 ready documentation systems
Quality Assurance
Every electro-polished pharmaceutical reactor fabricated by Roben Mfg undergoes rigorous quality assurance protocols:
- Material certifications with complete traceability
- Qualified welding procedures and welders per ASME BPE
- Surface finish verification and documentation
- Orbital weld inspection and documentation
- Hydrostatic and pneumatic testing per ASME requirements
- Complete IQ/OQ documentation packages available
Frequently Asked Questions
1. How do your reactors support vaccine process development?
Our electro-polished reactors provide development-scale equipment with production-equivalent surface quality. Comprehensive instrumentation captures process data, and flexible configuration supports optimization studies while maintaining conditions that translate to manufacturing scale.
2. Can your development reactors produce clinical trial vaccines?
Yes, our electro-polished reactors meet GMP requirements for clinical vaccine manufacturing. Documentation supports regulatory submissions, and quality systems maintain compliance with cGMP requirements for clinical trial material production.
3. How do you support scale-up to commercial vaccine production?
Our development-scale reactors use the same materials, surface quality, and design principles as commercial equipment. This consistency supports process comparability demonstrations and smooth technology transfer to manufacturing scale.
Contact Roben Mfg
Contact Roben Mfg today to discuss your vaccine development requirements. Our engineering team provides expert consultation on electro-polished reactor design, surface finish specifications, and complete pharmaceutical vessel solutions.
Phone: (281) 441-4088
Email: info@robenmfg.com
Website: www.robenmfg.com
